E. Kroon, S. Chottanapund, S. Buranapraditkun, C. Sacdalan, D. Colby, N. Chomchey, P. Prueksakaew, S. Pinyakorn, R. Trichavaroj, S. Vasan, S. Manasnayakorn, C. Reilly, E. Helgeson, Jodi L Anderson, C. David, Jacob J. Zulk, M. de Souza, S. Tovanabutra, A. Schuetz, M. Robb, D. Douek, N. Phanuphak, A. Haase, J. Ananworanich, T. Schacker
{"title":"Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of Infection","authors":"E. Kroon, S. Chottanapund, S. Buranapraditkun, C. Sacdalan, D. Colby, N. Chomchey, P. Prueksakaew, S. Pinyakorn, R. Trichavaroj, S. Vasan, S. Manasnayakorn, C. Reilly, E. Helgeson, Jodi L Anderson, C. David, Jacob J. Zulk, M. de Souza, S. Tovanabutra, A. Schuetz, M. Robb, D. Douek, N. Phanuphak, A. Haase, J. Ananworanich, T. Schacker","doi":"10.1093/infdis/jiac089","DOIUrl":null,"url":null,"abstract":"Abstract Starting antiretroviral therapy (ART) in Fiebig 1 acute HIV infection limits the size of viral reservoirs in lymphoid tissues, but does not impact time to virus rebound during a treatment interruption. To better understand why the reduced reservoir size did not increase the time to rebound we measured the frequency and location of HIV RNA+ cells in lymph nodes from participants in the RV254 acute infection cohort. HIV RNA+ cells were detected more frequently and in greater numbers when ART was initiated in Fiebig 1 compared to later Fiebig stages and were localized to the T-cell zone compared to the B-cell follicle with treatment in later Fiebig stages. Variability of virus production in people treated during acute infection suggests that the balance between virus-producing cells and the immune response to clear infected cells rapidly evolves during the earliest stages of infection. Clinical Trials Registration: NCT02919306.","PeriodicalId":22572,"journal":{"name":"The Indonesian Journal of Infectious Diseases","volume":"15 4 1","pages":"2167 - 2175"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Indonesian Journal of Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/infdis/jiac089","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
Abstract Starting antiretroviral therapy (ART) in Fiebig 1 acute HIV infection limits the size of viral reservoirs in lymphoid tissues, but does not impact time to virus rebound during a treatment interruption. To better understand why the reduced reservoir size did not increase the time to rebound we measured the frequency and location of HIV RNA+ cells in lymph nodes from participants in the RV254 acute infection cohort. HIV RNA+ cells were detected more frequently and in greater numbers when ART was initiated in Fiebig 1 compared to later Fiebig stages and were localized to the T-cell zone compared to the B-cell follicle with treatment in later Fiebig stages. Variability of virus production in people treated during acute infection suggests that the balance between virus-producing cells and the immune response to clear infected cells rapidly evolves during the earliest stages of infection. Clinical Trials Registration: NCT02919306.